Morgan Ryan W, Reeder Ron W, Carcillo Joseph A, Carpenter Todd C, Fitzgerald Julie C, Graham Kathryn, Kilbaugh Todd J, Meert Kathleen L, Nadkarni Vinay M, Palmer Chella A, Sharron Matthew P, Weiss Scott L, Wolfe Heather A, Ahmed Tageldin, Bell Michael J, Bishop Robert, Burns Candice, Diddle J Wesley, Fink Ericka L, Franzon Deborah, Frazier Aisha H, Friess Stuart H, Hehir David A, Horvat Christopher M, Huard Leanna L, Maa Tensing, McQuillen Patrick S, Mourani Peter M, Naim Maryam Y, Pollack Murray M, Sapru Anil, Srivastava Neeraj, Yates Andrew R, Berg Robert A, Sutton Robert M
Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA.
Department of Pediatrics, University of Utah, Salt Lake City, UT.
Crit Care Med. 2025 Jun 25. doi: 10.1097/CCM.0000000000006739.
Prearrest sepsis has been associated with particularly poor outcomes among children who suffer in-hospital cardiac arrest (IHCA), but there is a paucity of dedicated studies on the topic. In this study of children receiving cardiopulmonary resuscitation (CPR) in the ICU, our objective was to determine the associations of sepsis with IHCA outcomes and intraarrest physiology.
Prospectively designed secondary analysis of the ICU Resuscitation Project clinical trial (NCT02837497).
The 18 pediatric and pediatric cardiac ICUs at ten children's hospitals in the United States.
Children (≤ 18 yr) with an index IHCA event.
None.
The primary exposure was a prearrest diagnosis of sepsis. The primary survival outcome was survival to hospital discharge with favorable neurologic outcome (Pediatric Cerebral Performance Category score 1-3 or unchanged from baseline). The primary physiologic outcome was average diastolic blood pressure (DBP) during CPR. Multivariable regression models controlling for a priori covariates assessed the relationship between sepsis and outcomes. Of 1129 children with index IHCAs, 184 (16.3%) had prearrest sepsis. Patients with sepsis had greater prearrest comorbidities, higher prearrest severity of illness, and higher Vasoactive-Inotropic Scores than patients without sepsis. They more frequently had hypotension as the cause of IHCA, had longer durations of CPR, and more frequently received epinephrine and sodium bicarbonate during CPR. They less frequently achieved survival with favorable neurologic outcome (52/184 [28.3%] vs. 552/945 [58.4%]; p < 0.001; adjusted relative risk, 0.54; 95% CI, 0.43-0.68; p < 0.001). Intraarrest DBPs did not differ between patients with vs. without sepsis. Following IHCA, event survivors with sepsis had higher vasoactive requirements, more frequently experienced hypotension, and continued to have greater mortality rates through 48 hours postarrest.
Children with prearrest sepsis had worse survival outcomes, similar intraarrest DBPs, and greater pre and postarrest severity of illness than children without sepsis.
在住院期间发生心脏骤停(IHCA)的儿童中,心脏骤停前发生的脓毒症与特别差的预后相关,但关于该主题的专门研究很少。在这项对在重症监护病房(ICU)接受心肺复苏(CPR)的儿童的研究中,我们的目的是确定脓毒症与IHCA预后及心脏骤停期间生理状况之间的关联。
对ICU复苏项目临床试验(NCT02837497)进行前瞻性设计的二次分析。
美国十家儿童医院的18个儿科及小儿心脏重症监护病房。
发生首次IHCA事件的儿童(≤18岁)。
无。
主要暴露因素是心脏骤停前诊断为脓毒症。主要生存结局是存活至出院且神经功能预后良好(小儿脑功能分类评分1 - 3或与基线相比无变化)。主要生理结局是心肺复苏期间的平均舒张压(DBP)。控制先验协变量的多变量回归模型评估了脓毒症与结局之间的关系。在1129例发生首次IHCA的儿童中,184例(16.3%)在心脏骤停前患有脓毒症。与无脓毒症的患者相比,脓毒症患者在心脏骤停前有更多的合并症、更高的疾病严重程度以及更高的血管活性药物 - 正性肌力药物评分。他们因IHCA导致低血压的情况更常见,心肺复苏持续时间更长,并且在心肺复苏期间更频繁地接受肾上腺素和碳酸氢钠治疗。他们存活且神经功能预后良好的情况较少见(52/184 [28.3%] 对552/945 [58.4%];p < 0.001;调整后的相对风险,0.54;95%可信区间,0.43 - 0.68;p < 0.001)。有脓毒症与无脓毒症患者在心脏骤停期间的舒张压无差异。在IHCA之后,脓毒症事件幸存者有更高的血管活性药物需求,更频繁地出现低血压,并且在心脏骤停后48小时内死亡率持续更高。
与无脓毒症的儿童相比,心脏骤停前患有脓毒症的儿童生存结局更差,心脏骤停期间的舒张压相似,且心脏骤停前后的疾病严重程度更高。